NYSE:CTLT

Catalent News Headlines

$107.03
+0.85 (+0.80 %)
(As of 05/7/2021 01:09 PM ET)
Add
Compare
Today's Range
$106.18
$109.24
50-Day Range
$102.13
$115.69
52-Week Range
$67.97
$127.68
Volume11,360 shs
Average Volume1.07 million shs
Market Capitalization$18.22 billion
P/E Ratio68.17
Dividend YieldN/A
Beta1.5

Headlines

Catalent (NYSE CTLT) News Headlines Today

SourceHeadline
Catalent (NYSE:CTLT) Upgraded to "Buy" by Zacks Investment ResearchCatalent (NYSE:CTLT) Upgraded to "Buy" by Zacks Investment Research
marketbeat.com - April 27 at 8:48 PM
Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing - Yahoo FinanceCatalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing - Yahoo Finance
finance.yahoo.com - May 6 at 12:55 PM
Catalent, Inc. 2021 Q3 - Results - Earnings Call PresentationCatalent, Inc. 2021 Q3 - Results - Earnings Call Presentation
seekingalpha.com - May 6 at 10:24 AM
Catalent (NYSE:CTLT) Releases FY 2021 Earnings GuidanceCatalent (NYSE:CTLT) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 4 at 11:30 PM
Catalent Inc (CTLT) Q3 2021 Earnings Call Transcript - The Motley FoolCatalent Inc (CTLT) Q3 2021 Earnings Call Transcript - The Motley Fool
fool.com - May 4 at 10:49 PM
Catalent (CTLT) Tops Q3 Earnings and Revenue Estimates - Yahoo FinanceCatalent (CTLT) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 4 at 5:49 PM
Catalent, Inc. (CTLT) CEO John Chiminski On Q3 2021 Results - Earnings Call Transcript - Seeking AlphaCatalent, Inc. (CTLT) CEO John Chiminski On Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 4 at 5:49 PM
Catalent Inc (CTLT) Q3 2021 Earnings Call TranscriptCatalent Inc (CTLT) Q3 2021 Earnings Call Transcript
finance.yahoo.com - May 4 at 5:48 PM
Catalent (NYSE:CTLT) Posts Quarterly  Earnings Results, Beats Estimates By $0.09 EPSCatalent (NYSE:CTLT) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS
americanbankingnews.com - May 4 at 4:29 PM
Catalent (NYSE:CTLT)  Shares Down 8.8% Catalent (NYSE:CTLT) Shares Down 8.8%
americanbankingnews.com - May 4 at 1:16 PM
Catalent: Q3 Earnings Insights - BenzingaCatalent: Q3 Earnings Insights - Benzinga
benzinga.com - May 4 at 12:48 PM
Catalent (CTLT) Tops Q3 Earnings and Revenue EstimatesCatalent (CTLT) Tops Q3 Earnings and Revenue Estimates
finance.yahoo.com - May 4 at 12:48 PM
Catalent, Inc. Reports Third Quarter Fiscal 2021 Results - Business WireCatalent, Inc. Reports Third Quarter Fiscal 2021 Results - Business Wire
businesswire.com - May 4 at 7:47 AM
Catalent, Inc. Reports Third Quarter Fiscal 2021 ResultsCatalent, Inc. Reports Third Quarter Fiscal 2021 Results
finance.yahoo.com - May 4 at 7:47 AM
Catalent, Inc. (NYSE:CTLT) Receives Average Recommendation of "Buy" from BrokeragesCatalent, Inc. (NYSE:CTLT) Receives Average Recommendation of "Buy" from Brokerages
americanbankingnews.com - April 29 at 9:32 AM
Should Weakness in Catalent, Inc.s (NYSE:CTLT) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo FinanceShould Weakness in Catalent, Inc.'s (NYSE:CTLT) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo Finance
finance.yahoo.com - April 23 at 9:31 AM
Should Weakness in Catalent, Inc.s (NYSE:CTLT) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?Should Weakness in Catalent, Inc.'s (NYSE:CTLT) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
finance.yahoo.com - April 23 at 9:31 AM
Regeneron and 4 More Biopharma Stocks That Look CheapRegeneron and 4 More Biopharma Stocks That Look Cheap
finance.yahoo.com - April 21 at 1:03 PM
Catalent, Inc. (NYSE:CTLT) Expected to Announce Earnings of $0.76 Per ShareCatalent, Inc. (NYSE:CTLT) Expected to Announce Earnings of $0.76 Per Share
americanbankingnews.com - April 20 at 8:18 PM
Catalent, Inc. Announces Third Quarter Fiscal Year 2021 Earnings Conference Webcast - Yahoo FinanceCatalent, Inc. Announces Third Quarter Fiscal Year 2021 Earnings Conference Webcast - Yahoo Finance
finance.yahoo.com - April 19 at 12:29 PM
Catalent, Inc. Announces Third Quarter Fiscal Year 2021 Earnings Conference WebcastCatalent, Inc. Announces Third Quarter Fiscal Year 2021 Earnings Conference Webcast
finance.yahoo.com - April 19 at 12:29 PM
Catalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity - Yahoo FinanceCatalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity - Yahoo Finance
finance.yahoo.com - April 13 at 8:03 PM
Investors Who Bought Catalent (NYSE:CTLT) Shares Five Years Ago Are Now Up 267% - NasdaqInvestors Who Bought Catalent (NYSE:CTLT) Shares Five Years Ago Are Now Up 267% - Nasdaq
nasdaq.com - April 13 at 2:45 PM
Is CTLT Stock A Buy or Sell?Is CTLT Stock A Buy or Sell?
finance.yahoo.com - April 12 at 9:41 PM
Catalent signs deal with Moderna to speed up U.S. vaccine output - ReutersCatalent signs deal with Moderna to speed up U.S. vaccine output - Reuters
reuters.com - April 8 at 9:45 AM
Catalent Experts to Discuss Supply Chain for New Modalities, and Direct-to-Patient Clinical Supply for Decentralized Trials at GCSG Events in April - Yahoo FinanceCatalent Experts to Discuss Supply Chain for New Modalities, and Direct-to-Patient Clinical Supply for Decentralized Trials at GCSG Events in April - Yahoo Finance
finance.yahoo.com - April 7 at 12:45 PM
Catalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine - Yahoo FinanceCatalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine - Yahoo Finance
finance.yahoo.com - April 7 at 12:45 PM
Catalent (CTLT) Expands Deal With Moderna for COVID-19 VaccineCatalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine
finance.yahoo.com - April 7 at 12:45 PM
Moderna, Catalent Expand Collaboration For Vial Filling Of COVID-19 Vaccine & Clinical Portfolio - NasdaqModerna, Catalent Expand Collaboration For Vial Filling Of COVID-19 Vaccine & Clinical Portfolio - Nasdaq
nasdaq.com - April 7 at 7:44 AM
Catalent To Boost Output Of Finished Vials For Modernas COVID-19 Shot: WSJ - Yahoo FinanceCatalent To Boost Output Of Finished Vials For Moderna's COVID-19 Shot: WSJ - Yahoo Finance
finance.yahoo.com - April 7 at 7:44 AM
Contract manufacturer Catalent to double Modernas COVID-19 vaccine production - WSJ - ReutersContract manufacturer Catalent to double Moderna's COVID-19 vaccine production - WSJ - Reuters
reuters.com - April 6 at 2:43 PM
ABEC CSR® Single-Use Fermenters to Support Catalent Cell & Gene Therapy Manufacturing Expansion - Business WireABEC CSR® Single-Use Fermenters to Support Catalent Cell & Gene Therapy Manufacturing Expansion - Business Wire
businesswire.com - April 6 at 9:43 AM
Catalent To Boost Output Of Finished Vials For Modernas COVID-19 Shot: WSJCatalent To Boost Output Of Finished Vials For Moderna's COVID-19 Shot: WSJ
feeds.benzinga.com - April 6 at 7:22 AM
Catalent (CTLT) Shines Bright in Madison Fund’s Q4 2020 Portfolio - Yahoo FinanceCatalent (CTLT) Shines Bright in Madison Fund’s Q4 2020 Portfolio - Yahoo Finance
finance.yahoo.com - March 30 at 3:56 AM
Catalent (CTLT) Shines Bright in Madison Fund’s Q4 2020 PortfolioCatalent (CTLT) Shines Bright in Madison Fund’s Q4 2020 Portfolio
finance.yahoo.com - March 29 at 5:53 PM
Catalent: COVID-19 Opportunities Continue To Materialize - Seeking AlphaCatalent: COVID-19 Opportunities Continue To Materialize - Seeking Alpha
seekingalpha.com - March 29 at 12:53 PM
Time to Focus on Catalent (CTLT) for Strong Earnings Growth Potential - Yahoo FinanceTime to Focus on Catalent (CTLT) for Strong Earnings Growth Potential - Yahoo Finance
finance.yahoo.com - March 26 at 12:56 AM
Time to Focus on Catalent (CTLT) for Strong Earnings Growth Potential - NasdaqTime to Focus on Catalent (CTLT) for Strong Earnings Growth Potential - Nasdaq
nasdaq.com - March 25 at 7:55 PM
Heres Why Im Avoiding AstraZeneca StockHere's Why I'm Avoiding AstraZeneca Stock
finance.yahoo.com - March 25 at 2:49 PM
Time to Focus on Catalent (CTLT) for Strong Earnings Growth PotentialTime to Focus on Catalent (CTLT) for Strong Earnings Growth Potential
finance.yahoo.com - March 25 at 2:49 PM
J&J plant authorization clears way for big boost in U.S. COVID-19 shots - ReutersJ&J plant authorization clears way for big boost in U.S. COVID-19 shots - Reuters
reuters.com - March 25 at 9:49 AM
JNJ COVID-19 vaccine deliveries to rise as Catalent facility gets FDA nod - Seeking AlphaJNJ COVID-19 vaccine deliveries to rise as Catalent facility gets FDA nod - Seeking Alpha
seekingalpha.com - March 25 at 9:49 AM
Catalent Gets FDA OK to Produce More Doses of J&J Vaccine: Report - TheStreetCatalent Gets FDA OK to Produce More Doses of J&J Vaccine: Report - TheStreet
thestreet.com - March 25 at 9:49 AM
After inspection, AstraZeneca says 29 million COVID-19 doses in Italy are for EU, poorer nations - ReutersAfter inspection, AstraZeneca says 29 million COVID-19 doses in Italy are for EU, poorer nations - Reuters
reuters.com - March 24 at 11:47 PM
Catalent Stock Gives Every Indication Of Being Significantly OvervaluedCatalent Stock Gives Every Indication Of Being Significantly Overvalued
finance.yahoo.com - March 24 at 6:46 PM
Italy Police Searched Plant With Reported 29 Million Astra Doses - BloombergItaly Police Searched Plant With Reported 29 Million Astra Doses - Bloomberg
bloomberg.com - March 24 at 8:44 AM
J&J Partner Catalent Gets Key U.S. Clearance to Make Vaccine - BloombergJ&J Partner Catalent Gets Key U.S. Clearance to Make Vaccine - Bloomberg
bloomberg.com - March 23 at 5:43 PM
Catalent Gets FDA OK to Produce More Doses of J&J Vaccine: ReportCatalent Gets FDA OK to Produce More Doses of J&J Vaccine: Report
finance.yahoo.com - March 23 at 5:43 PM
UPDATE 3-J&J plant authorization clears way for big boost in U.S. COVID-19 shotsUPDATE 3-J&J plant authorization clears way for big boost in U.S. COVID-19 shots
finance.yahoo.com - March 23 at 5:43 PM
Catalent Inc (CTLT) Chair & CEO John R Chiminski Sold $23.8 million of SharesCatalent Inc (CTLT) Chair & CEO John R Chiminski Sold $23.8 million of Shares
finance.yahoo.com - March 23 at 12:42 PM
Cybin inks drug development agreement with Catalent - Seeking AlphaCybin inks drug development agreement with Catalent - Seeking Alpha
seekingalpha.com - March 22 at 9:40 PM
This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.